CompanionDx® Releases New Website at

Share Article

CompanionDx Releases New Website Highlighting Company's Integrated Genomic Solutions

CompanionDx Logo jpeg

CompanionDx announces the release of its new website, which provides greater clarity into the company’s integrated genomic solutions and how they can be used effectively in multiple disease states to optimize patient therapy.

Physicians, patients and other interested parties seeking information on CompanionDx can navigate quickly through the site’s user-friendly navigation areas. In the provider solutions section, the site unveils how integrated genomic solutions evaluate germline variants and somatic mutations to inform therapy decisions across the patient journey. In the About Us section, users will learn more about CompanionDx’s proven leadership team and what compels them to make healthcare safer and more effective for every patient. The new website also gives visitors easier access to the physician and healthcare professional portals; the UPGRADE registry to provide data and insight to help further the field of genomics through pharmacogenomics testing; and information about CompanionDx’s patient financial assistance program.

CompanionDx is also keeping their audiences up-to-date with industry insight through the website’s Resources section and through the company’s LinkedIn, Twitter and Facebook pages. CompanionDx will continue to update the site with additional information to help ensure quality patient care through precision medicine.

# # #

About CompanionDx
CompanionDx is the integrated genomic diagnostic and decision support company. Headquartered in Houston, CompanionDx is committed to enhancing and extending patients’ lives by providing physicians with the actionable intelligence they need. Only CompanionDx has the integrated genomic solutions, combining diagnostics such as next-generation sequencing, pharmacogenomics and drug monitoring. CompanionDx’s certified molecular biologists, pathologists and technologists conduct all tests within two CLIA-certified, high-complexity labs, while continually seeking ways to improve the approach to patient therapy. From tumor diagnosis to treatment, CompanionDx delivers the clinical insight physicians need while continuing to advance the field with data intelligence. For more information about how CompanionDx is redefining the patient journey, visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Stacey Little
+1 832-701-0460
Email >
Visit website